{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":9,"description":"Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment.\n\nPerflubutane Microbubble: Given subdermally\n\nContrast-Enhanced Ultrasound: Undergo ultrasound","id":"EG000","otherNumAffected":0,"otherNumAtRisk":9,"seriousNumAffected":0,"seriousNumAtRisk":9,"title":"Diagnostic (Perflubutane Microbubble, Ultrasound)"}],"frequencyThreshold":"0","timeFrame":"The PI will follow AEs with start dates occurring any time after informed consent is obtained until 7 (for non-serious AEs) or 30 days (for SAEs) after the last day of study participation. Events will be followed for outcome information until resolution or stabilization."}